SGCB and memory impairment: Subchronic L-NAME treatment successfully induced short-term memory impairments, and the sGC stimulator BAY-747 fully reversed this at a dose of 0.3 mg/kg p.o. Interestingly, the sGC activator runcaciguat did not reverse L-NAME induced memory impairments at 0.3 mg/kg and 1.0 mg/kg p.o., despite the effectiveness of these doses in the long-term memory paradigm.